Combination Dosing Regimen Not Obvious Despite Overlapping Prior-Art Ranges Justin J. Gillett & Alex Martin del Campo JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. Before Prost, Reyna, and Taranto….
Space Technology Investments Clear the Launch Tower in 2025 Tom Cowan Investments in space technology are off to a strong start in the first half of 2025. The rising trend…
July Federal Circuit Newsletter (Japanese) July Federal Circuit Newsletter (Chinese) Combination Dosing Regimen Not Obvious Despite Overlapping Prior-Art Ranges In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., Appeal…
Speaking with Law360 for an article on career prospects and job satisfaction for recent law school graduates, associate Zach Rufa said he felt “incredibly lucky” to have begun his legal…
In the latest installment of their Law360 column on recent noteworthy Federal Circuit decisions, partners Sean Murray and Jeremiah Helm examined the outcome in Eye Therapies LLC v. Slayback Pharma…
New blog to provide perspectives and insights on the aerospace industry, ranging from IP issues to policy, innovation and investment trends IRVINE, Calif., July 29, 2025 – Knobbe Martens is…
Speaking with aerospace industry publication The Space Report, partner Tom Cowan shared his perspective on the state of investment in the space sector across startups and mature companies. In the…
IRVINE, Calif., July 16, 2025 – Knobbe Martens is proud to share that the firm was honored with the “Community Partner” Award at the Orange County Asian American Bar Association…
In the Daily Journal article “9th Circuit Weighs Tattoo Copyright Dispute between Kat Von D and Photographer,” Knobbe Martens partner Mark Lezama offered insight into the latest developments in an…
June Federal Circuit Newsletter (Japanese) June Federal Circuit Newsletter (Chinese) No Injury, No Appeal: Patent Owners Must Show Actual Injury for Article III Standing In Dolby Laboratories Licensing Corporation…
